Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus DOI Open Access
Ian Ganly, Liying Yang, Rachel Giese

et al.

International Journal of Cancer, Journal Year: 2019, Volume and Issue: 145(3), P. 775 - 784

Published: Jan. 24, 2019

Over the past decade, there has been a change in epidemiology of oral cavity squamous cell cancer (OC‐SCC). Many new cases OC‐SCC lack recognized risk factors smoking, alcohol and human papilloma virus. The aim this study was to determine if microbiome may be associated with nonsmoking HPV negative patients. We compared HPV‐negative nonsmoker OC‐SCC(n = 18), premalignant lesions(PML) (n 8) normal control patients 12). Their sampled by wash defined 16S rRNA gene sequencing. report that periodontal pathogens Fusobacterium, Prevotella, Alloprevotella were enriched while commensal Streptococcus depleted OC‐SCC. Based on four genera plus marker genus Veillonella for PML, we classified into two types. Gene/pathway analysis revealed progressive increase genes encoding HSP90 ligands TLRs 1, 2 4 along controls→PML → progression sequence. Our findings suggest an association between non smoking

Language: Английский

A defined commensal consortium elicits CD8 T cells and anti-cancer immunity DOI
Takeshi Tanoue, Satoru Morita, Damian R. Plichta

et al.

Nature, Journal Year: 2019, Volume and Issue: 565(7741), P. 600 - 605

Published: Jan. 23, 2019

Language: Английский

Citations

914

Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer DOI Creative Commons
Mingyang Song, Andrew T. Chan, Jun Sun

et al.

Gastroenterology, Journal Year: 2019, Volume and Issue: 158(2), P. 322 - 340

Published: Oct. 3, 2019

Language: Английский

Citations

593

Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects DOI Creative Commons
Simin Tang, Xueting Deng, Jian Zhou

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2019, Volume and Issue: 121, P. 109604 - 109604

Published: Nov. 13, 2019

Quercetin is a kind of flavonoid compounds that comes from nature and widely existed in the daily diet. Previous studies have found quercetin has many effects such as anti-inflammatory, anti-oxidation anti-cancer. Both vivo vitro experiments demonstrated can exert anti-tumor by altering cell cycle progression, inhibiting proliferation, promoting apoptosis, angiogenesis metastasis affecting autophagy. This review summarizes evidence for pharmacological potential inhibition on cancers, supporting viewpoint should be adequately considered therapeutic agent against various cancers.

Language: Английский

Citations

504

Gut Microbiota and Cancer: From Pathogenesis to Therapy DOI Open Access
Silvia Vivarelli, Rossella Salemi, Saverio Candido

et al.

Cancers, Journal Year: 2019, Volume and Issue: 11(1), P. 38 - 38

Published: Jan. 3, 2019

Cancer is a multifactorial pathology and it represents the second leading cause of death worldwide. In recent years, numerous studies highlighted dual role gut microbiota in preserving host’s health. Gut resident bacteria are able to produce number metabolites bioproducts necessary protect gut’s homeostasis. Conversely, several subpopulations may expand during pathological dysbiosis therefore high levels toxins capable, turn, trigger both inflammation tumorigenesis. Importantly, can interact with host either modulating directly epithelium or immune system. Numerous populating bacteria, called probiotics, have been identified as protective against genesis tumors. Given their capability homeostasis, probiotics currently tested help fight cancer patients subjected chemotherapy radiotherapy. Most recently, three independent show that specific species potentiate positive outcome anti-cancer immunotherapy. The highly significant studies, uncovering tight association between tumorigenesis, well therapy, here described. Lactobacillus rhamnosus GG (LGG), most studied probiotic model cancer, also reported. Overall, according findings summarized, novel strategies integrating such LGG, conventional therapies strongly encouraged.

Language: Английский

Citations

496

The gut microbiota influences anticancer immunosurveillance and general health DOI
Bertrand Routy, Vancheswaran Gopalakrishnan,

Romain Daillère

et al.

Nature Reviews Clinical Oncology, Journal Year: 2018, Volume and Issue: 15(6), P. 382 - 396

Published: April 10, 2018

Language: Английский

Citations

440

Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma DOI
Tuba N. Gide, James S. Wilmott, Richard A. Scolyer

et al.

Clinical Cancer Research, Journal Year: 2017, Volume and Issue: 24(6), P. 1260 - 1270

Published: Nov. 10, 2017

Immune checkpoint inhibitors have revolutionized the treatment of patients with advanced-stage metastatic melanoma, as well many other solid cancers, yielding long-lasting responses and improved survival. However, a subset who initially respond to immunotherapy, later relapse develop therapy resistance (termed "acquired resistance"), whereas others do not at all "primary resistance"). Primary acquired are key clinical barriers further improving outcomes known mechanisms underlying each involves various components cancer immune cycle, interactions between multiple signaling molecules pathways. Due this complexity, current knowledge on is still incomplete. Overcoming requires thorough understanding evasion by tumors. In review, we explore primary immunotherapy in melanoma detail potential therapeutic strategies prevent overcome them. Clin Cancer Res; 24(6); 1260-70. ©2017 AACR.

Language: Английский

Citations

382

Modulating the microbiome to improve therapeutic response in cancer DOI Creative Commons
Jennifer L. McQuade, Carrie R. Daniel, Beth A. Helmink

et al.

The Lancet Oncology, Journal Year: 2019, Volume and Issue: 20(2), P. e77 - e91

Published: Feb. 1, 2019

Language: Английский

Citations

314

The oralome and its dysbiosis: New insights into oral microbiome-host interactions DOI Creative Commons
Allan Radaic, Yvonne L. Kapila

Computational and Structural Biotechnology Journal, Journal Year: 2021, Volume and Issue: 19, P. 1335 - 1360

Published: Jan. 1, 2021

The oralome is the summary of dynamic interactions orchestrated between ecological community oral microorganisms (comprised up to approximately 1000 species bacteria, fungi, viruses, archaea and protozoa - microbiome) that live in cavity host. These form a complex ecosystem thrive environment symbiotic relationship with human However, microbial composition significantly affected by interspecies host-microbial interactions, which turn, can impact health disease status In this review, we discuss inter-species take place examine how these change from healthy (eubiotic) (dysbiotic) states. We further dysbiotic signatures associated periodontitis caries their sequalae, (e.g., tooth/bone loss pulpitis), systemic diseases diseases, such as infective endocarditis, atherosclerosis, diabetes, Alzheimer's head neck/oral cancer. then current computational techniques assess microbiome changes. Lastly, novel for modulation may help prevention treatment, including standard hygiene methods, prebiotics, probiotics, use nano-sized drug delivery systems (nano-DDS), extracellular polymeric matrix (EPM) disruption, host response modulators.

Language: Английский

Citations

312

Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities DOI Creative Commons
Mansour Sedighi, Abed Zahedi Bialvaei, Michael R. Hamblin

et al.

Cancer Medicine, Journal Year: 2019, Volume and Issue: 8(6), P. 3167 - 3181

Published: April 5, 2019

Successful treatment of cancer remains a challenge, due to the unique pathophysiology solid tumors, and predictable emergence resistance. Traditional methods for therapy including radiotherapy, chemotherapy, immunotherapy all have their own limitations. A novel approach is bacteriotherapy, either used alone, or in combination with conventional methods, has shown positive effect on regression tumors inhibition metastasis. Bacteria-assisted tumor-targeted as therapeutic/gene/drug delivery vehicles great promise tumors. The use bacteria only, was found be effective some experimental models (tumor increased survival rate). In this article, we reviewed major advantages, challenges, prospective directions combinations tumor therapy.

Language: Английский

Citations

264

Human microbiome: an academic update on human body site specific surveillance and its possible role DOI Open Access

Elakshi Dekaboruah,

Mangesh Suryavanshi,

Dixita Chettri

et al.

Archives of Microbiology, Journal Year: 2020, Volume and Issue: 202(8), P. 2147 - 2167

Published: June 10, 2020

Language: Английский

Citations

247